GEOPTE scale of social cognition for psychosis;Escala GEOPTE de cognición social para la psicosis: GEOPTE (Grupo Español para la Optimización y Tratamiento de la Esquizofrenia)

Actas Espanolas de Psiquiatria

Volumn 31, Issue 3, 2003, Pages 120-128

  Sanjuán, Julio ^a,i   Prieto, L ^j   Olivares, J M ^b   Ros, S ^c   Montejo, A ^d   Ferre, F ^e   Mayoral, F ^f   Gonzalez Torres M A ^g   Bousono M ^h  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL XERAL CÍES   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^e Centro de Salud Mental   (Spain)

^f HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^g HOSPITAL DE BASURTO   (Spain)

^h UNIVERSITY OF OVIEDO   (Spain)

ⁱ UNIVERSITY OF VALENCIA   (Spain)

^j NONE

more..

Author keywords

GEOPTE Scale; Psychosis; Schizophrenia; Social cognition

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CAREGIVER; CLINICAL PRACTICE; COGNITION; CONTROLLED STUDY; DELIRIUM; DEPRESSION; FACTORIAL ANALYSIS; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL RECORD; MENTAL CAPACITY; MOOD; PSYCHOMETRY; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SELF CONCEPT; SOCIAL ASPECT; VALIDATION PROCESS; VARIANCE;

COGNITION DISORDERS; FEASIBILITY STUDIES; HUMANS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIAL PERCEPTION;

EID: 0043068335     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bulbena A, Berrios G, Fernández de Larrinoa P. Medición clínica en Psiquiatría y Psicología. Barcelona: Masson, 2000.
2. McEvoy JP. Guide to assessment scales in schizophrenia. London: Science Press, 2000.
3. David AS, Cutting JC. The neuropsychology of schizophrenia. Hove: Lawrence Erlbaum, 1994.
4. Pantelis C, Nelson H, Barnes TR. Schizophrenia a europsychological perspective. Chichester: John Wiley & Sons, 1996.
5. Frith CD. Hacia una geografia de la esquizofrenia. Mundo Científico 1996;172:868-73.
6. Sanjuán J. Guía para la evaluación del déficit cognitivo en la esquizofrenia. Madrid: Grupo Geopte, 2001.
7. Corrigan PW, Penn DL. Social cognition and schizophrenia. Washington: American Psychological Association, 2000.
8. Brothers L. A biological perspective on enpathy. Am J Psychiatry 1989;146(1):10-9.
9. Frith CD, Corcoran R. Exploring «theory of mind» in people with schizophrenia. Psychol Med 1996;26(3):521-30.
10. Sharma T, Harvey P. Cognition in schizophrenia. Impairmaints, importance and treatment strategies. New York: Oxford University Press, 2000.
11. Gilbody SM, House AO, Sheldon TA. Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry 2002;180:101-3.
12. GENCD (Grupo Español de Neurología de la Conducta y Demencia). Guía en demencias. Barcelona: Masson, 2000.
13. Startup M. Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship. Psychol Med 1996;26(6):1277-81.
14. rd ed. New York: McGraw-Hill, 1994.
15. Crocker L, Algina J. Introduction to classical and modern test theory. Fort Worth: Harcourt Brace Jovanovich, 1986.
16. Suen HK. Principles of test theories. New Jersey: LEA, 1990.
17. Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use. Oxford: Oxford University Press, 1989.
18. Marková IS, Berrios GE, del Olmo F, Fernández Larrinoa P. Insight y memoria. En: Bulbena A, Berrios G, Fernández de Larrinoa P, editores. Medición clínica en Psiquiatría y Psicología. Barcelona: Masson, 2000.
19. Pickup GJ, Frith CD. Theory of mind impairments in schizophrenia: symptomatology, severity and specificity. Psychol Med 2001;31(2):207-20.
20. Hogarty GE, Flesher S. Developmental theory for a cognitive enhancement therapy of schizophreria. Schizophr Bull 1999;25(4):677-92.
21. Littrell KH. Psychopharmacology and social reintegration. En: Breier et al, editores. Current issues in the psychopharmachology of schizophrenia. Philadelphia: Lippincott Williams & Wilkins, 2001.